Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1998 Sep;51(9):662–666. doi: 10.1136/jcp.51.9.662

Helicobacter pylori and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomach.

I O Baas 1, B P van Rees 1, A Musler 1, M E Craanen 1, G N Tytgat 1, F M van den Berg 1, G J Offerhaus 1
PMCID: PMC500902  PMID: 9930069

Abstract

AIM: To evaluate similarities and differences between gastric stump cancer and conventional carcinoma in the non-operated stomach. METHODS: 26 stump carcinomas were compared with 24 conventional stomach cancers. Stage, histological type, and demographics were comparable in the two groups. Expression of p53 and p21-Waf1/Cip1 was evaluated by immunohistochemical staining. Helicobacter pylori infection was evaluated by examining haematoxylin-eosin stained slides and immunohistochemistry. Epstein-Barr virus infection was evaluated by RNA in situ hybridisation. RESULTS: Expression of p53 and p21-Waf1/Cip1 was similar in both groups and positive in more than half of the patients. H pylori infection was observed in six stump carcinomas and 17 conventional carcinomas in the intact stomach (p < 0.01). RNA in situ hybridisation (EBER1-ISH) for Epstein-Barr virus was positive in nine stump carcinomas and two carcinomas in the non-operated stomach (p < 0.05). CONCLUSIONS: There appear to be aetiological differences between stump carcinoma and cancer in the intact stomach. Further study of these differences may improve our understanding of gastric carcinogenesis in general.

Full text

PDF
663

Images in this article

663Image
on p.663
664Image
on p.664

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baas I. O., Mulder J. W., Offerhaus G. J., Vogelstein B., Hamilton S. R. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol. 1994 Jan;172(1):5–12. doi: 10.1002/path.1711720104. [DOI] [PubMed] [Google Scholar]
  2. Baas I. O., van den Berg F. M., Mulder J. W., Clement M. J., Slebos R. J., Hamilton S. R., Offerhaus G. J. Potential false-positive results with antigen enhancement for immunohistochemistry of the p53 gene product in colorectal neoplasms. J Pathol. 1996 Mar;178(3):264–267. doi: 10.1002/(SICI)1096-9896(199603)178:3<264::AID-PATH485>3.0.CO;2-#. [DOI] [PubMed] [Google Scholar]
  3. Baker S. J., Preisinger A. C., Jessup J. M., Paraskeva C., Markowitz S., Willson J. K., Hamilton S., Vogelstein B. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res. 1990 Dec 1;50(23):7717–7722. [PubMed] [Google Scholar]
  4. Caygill C. P., Hill M. J., Kirkham J. S., Northfield T. C. Mortality from gastric cancer following gastric surgery for peptic ulcer. Lancet. 1986 Apr 26;1(8487):929–931. doi: 10.1016/s0140-6736(86)91041-x. [DOI] [PubMed] [Google Scholar]
  5. Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988 Jul 1;48(13):3554–3560. [PubMed] [Google Scholar]
  6. Correa P. Precursors of gastric and esophageal cancer. Cancer. 1982 Dec 1;50(11 Suppl):2554–2565. [PubMed] [Google Scholar]
  7. Craanen M. E., Blok P., Dekker W., Offerhaus G. J., Tytgat G. N. Chronology of p53 protein accumulation in gastric carcinogenesis. Gut. 1995 Jun;36(6):848–852. doi: 10.1136/gut.36.6.848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Goldstone A. R., Quirke P., Dixon M. F. Helicobacter pylori infection and gastric cancer. J Pathol. 1996 Jun;179(2):129–137. doi: 10.1002/(SICI)1096-9896(199606)179:2<129::AID-PATH504>3.0.CO;2-C. [DOI] [PubMed] [Google Scholar]
  9. Harn H. J., Chang J. Y., Wang M. W., Ho L. I., Lee H. S., Chiang J. H., Lee W. H. Epstein-Barr virus-associated gastric adenocarcinoma in Taiwan. Hum Pathol. 1995 Mar;26(3):267–271. doi: 10.1016/0046-8177(95)90056-x. [DOI] [PubMed] [Google Scholar]
  10. Howson C. P., Hiyama T., Wynder E. L. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev. 1986;8:1–27. doi: 10.1093/oxfordjournals.epirev.a036288. [DOI] [PubMed] [Google Scholar]
  11. Imai S., Koizumi S., Sugiura M., Tokunaga M., Uemura Y., Yamamoto N., Tanaka S., Sato E., Osato T. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):9131–9135. doi: 10.1073/pnas.91.19.9131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. La Vecchia C., Lucchini F., Negri E., Boyle P., Maisonneuve P., Levi F. Trends of cancer mortality in Europe, 1955-1989: I, Digestive sites. Eur J Cancer. 1992;28(1):132–235. doi: 10.1016/0959-8049(92)90402-n. [DOI] [PubMed] [Google Scholar]
  13. Maruyama K., Okabayashi K., Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg. 1987 Aug;11(4):418–425. doi: 10.1007/BF01655804. [DOI] [PubMed] [Google Scholar]
  14. Ming S. C. Gastric carcinoma. A pathobiological classification. Cancer. 1977 Jun;39(6):2475–2485. doi: 10.1002/1097-0142(197706)39:6<2475::aid-cncr2820390626>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  15. Offerhaus G. J. Gastric stump cancer: lessons from old specimens. Lancet. 1994 Jan 8;343(8889):66–67. doi: 10.1016/s0140-6736(94)90807-9. [DOI] [PubMed] [Google Scholar]
  16. Offerhaus G. J., Rieu P. N., Jansen J. B., Joosten H. J., Lamers C. B. Prospective comparative study of the influence of postoperative bile reflux on gastric mucosal histology and Campylobacter pylori infection. Gut. 1989 Nov;30(11):1552–1557. doi: 10.1136/gut.30.11.1552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Offerhaus G. J., Stadt J., Huibregtse K., Tytgat G. Endoscopic screening for malignancy in the gastric remnant: the clinical significance of dysplasia in gastric mucosa. J Clin Pathol. 1984 Jul;37(7):748–754. doi: 10.1136/jcp.37.7.748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Offerhaus G. J., Tersmette A. C., Giardiello F. M., Huibregtse K., Vandenbroucke J. P., Tytgat G. N. Evaluation of endoscopy for early detection of gastric-stump cancer. Lancet. 1992 Jul 4;340(8810):33–35. doi: 10.1016/0140-6736(92)92433-g. [DOI] [PubMed] [Google Scholar]
  19. Offerhaus G. J., Tersmette A. C., Huibregtse K., van de Stadt J., Tersmette K. W., Stijnen T., Hoedemaeker P. J., Vandenbroucke J. P., Tytgat G. N. Mortality caused by stomach cancer after remote partial gastrectomy for benign conditions: 40 years of follow up of an Amsterdam cohort of 2633 postgastrectomy patients. Gut. 1988 Nov;29(11):1588–1590. doi: 10.1136/gut.29.11.1588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Offerhaus G. J., van de Stadt J., Huibregtse K., Tersmette A. C., Tytgat G. N. The mucosa of the gastric remnant harboring malignancy. Histologic findings in the biopsy specimens of 504 asymptomatic patients 15 to 46 years after partial gastrectomy with emphasis on nonmalignant lesions. Cancer. 1989 Aug 1;64(3):698–703. doi: 10.1002/1097-0142(19890801)64:3<698::aid-cncr2820640322>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  21. Saini A., Waxman J. Chemotherapy for gastric cancer. Gut. 1992 Sep;33(9):1153–1154. doi: 10.1136/gut.33.9.1153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Solcia E., Fiocca R., Luinetti O., Villani L., Padovan L., Calistri D., Ranzani G. N., Chiaravalli A., Capella C. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg Pathol. 1996;20 (Suppl 1):S8–22. doi: 10.1097/00000478-199600001-00003. [DOI] [PubMed] [Google Scholar]
  23. Szekely L., Selivanova G., Magnusson K. P., Klein G., Wiman K. G. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5455–5459. doi: 10.1073/pnas.90.12.5455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Tersmette A. C., Goodman S. N., Offerhaus G. J., Tersmette K. W., Giardiello F. M., Vandenbroucke J. P., Tytgat G. N. Multivariate analysis of the risk of stomach cancer after ulcer surgery in an Amsterdam cohort of postgastrectomy patients. Am J Epidemiol. 1991 Jul 1;134(1):14–21. doi: 10.1093/oxfordjournals.aje.a115988. [DOI] [PubMed] [Google Scholar]
  25. Tersmette A. C., Offerhaus G. J., Giardiello F. M., Brand R., Tersmette K. W., Tytgat G. N., Vandenbroucke J. P. Long-term prognosis after partial gastrectomy for benign conditions. Survival and smoking-related death of 2633 Amsterdam postgastrectomy patients followed up since surgery between 1931 and 1960. Gastroenterology. 1991 Jul;101(1):148–153. [PubMed] [Google Scholar]
  26. Tokunaga M., Land C. E., Uemura Y., Tokudome T., Tanaka S., Sato E. Epstein-Barr virus in gastric carcinoma. Am J Pathol. 1993 Nov;143(5):1250–1254. [PMC free article] [PubMed] [Google Scholar]
  27. Tokunaga M., Uemura Y., Tokudome T., Ishidate T., Masuda H., Okazaki E., Kaneko K., Naoe S., Ito M., Okamura A. Epstein-Barr virus related gastric cancer in Japan: a molecular patho-epidemiological study. Acta Pathol Jpn. 1993 Oct;43(10):574–581. doi: 10.1111/j.1440-1827.1993.tb03233.x. [DOI] [PubMed] [Google Scholar]
  28. Uchino S., Noguchi M., Ochiai A., Saito T., Kobayashi M., Hirohashi S. p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer. 1993 Jul 9;54(5):759–764. doi: 10.1002/ijc.2910540509. [DOI] [PubMed] [Google Scholar]
  29. Wright P. A., Williams G. T. Molecular biology and gastric carcinoma. Gut. 1993 Feb;34(2):145–147. doi: 10.1136/gut.34.2.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. el-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993 Nov 19;75(4):817–825. doi: 10.1016/0092-8674(93)90500-p. [DOI] [PubMed] [Google Scholar]
  31. el-Deiry W. S., Tokino T., Waldman T., Oliner J. D., Velculescu V. E., Burrell M., Hill D. E., Healy E., Rees J. L., Hamilton S. R. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res. 1995 Jul 1;55(13):2910–2919. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES